dr. yardley shares insight on the impact of biosimilars
Published 5 years ago • 68 plays • Length 0:43Download video MP4
Download video MP3
Similar videos
-
0:43
dr. yardley on the role of biosimilars in breast cancer
-
1:48
dr. markman on the concept of biosimilars in oncology
-
35:31
understanding biosimilars: how the availability of biosimilars will impact clinical practice
-
3:07
the promise of biosimilars
-
0:41
similarity of biosimilars and biologics
-
3:00
biosimilars: complex copycat drugs
-
4:12
the basics of biosimilars
-
3:33
biosimilars: manufacturing and inherent variation
-
1:44
dr. tripathy on the importance of biosimilars in oncology
-
9:26
the future direction of biosimilars
-
1:40
dr. pegram on the manufacturing process of biosimilars
-
3:45
what are biosimilars? how do they work for arthritis?
-
1:47
the biosimilar threat: which companies are at risk
-
5:20
data requirements for biosimilars
-
6:18
fda approves of biosimilar to infliximab – ibd in the news
-
0:53
brian lehman, mba, mha, rph: impact of biosimilar insulin on patient affordability
-
1:08
the impact of switching from a reference biologic to a biosimilar
-
1:32
the regulation of biosimilars
-
0:57
dr. somer on the expansion of biosimilars in oncology
-
1:37
dr. rugo discusses the regulatory process behind biosimilars
-
2:04
the impact of the fda's approval of the first 'biosimilar' drug
-
19:32
understanding biosimilars